Finch NA, Wang X, Baker MC, Heckman MG, Gendron TF, Bieniek KF, Wuu J, DeJesus-Hernandez M, Brown PH, Chew J, Jansen-West KR, Daughrity LM, Nicholson AM, Murray ME, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Petrucelli L, Boeve BF, Graff-Radford NR, Asmann YW, Dickson DW, Benatar M, Bowser R, Boylan KB, Rademakers R, van Blitterswijk M. Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers. Neurol Genet. 2017 Jun 7;3(4):e161. [PubMed Link]
Recent Posts
- Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation
- UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies
- ALS Center investigators host first international Pre-Symptomatic ALS Workshop
- CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant
- Phase III Trial Evaluating Arimoclomol for ALS Patients Reaches Full Enrollment
Recent Comments